Cargando…
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
• Controversial registration of aducanumab for Alzheimer's Disease; • Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug; • Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular co...
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616233/ https://www.ncbi.nlm.nih.gov/pubmed/36324416 http://dx.doi.org/10.1016/j.cccb.2022.100044 |
| _version_ | 1784820605323837440 |
|---|---|
| author | Wallin, Anders Alladi, Suvarna Black, Sandra E Chen, Christopher Greenberg, Steven M Gustafson, Deborah Isaacs, Jeremy D Jokinen, Hanna Kalaria, Raj Mok, Vincent Pantoni, Leonardo Pasquier, Florence Roman, Gustavo C Rosenberg, Gary A. Schmidt, Reinhold Smith, Eric E Hainsworth, Atticus H |
| author_facet | Wallin, Anders Alladi, Suvarna Black, Sandra E Chen, Christopher Greenberg, Steven M Gustafson, Deborah Isaacs, Jeremy D Jokinen, Hanna Kalaria, Raj Mok, Vincent Pantoni, Leonardo Pasquier, Florence Roman, Gustavo C Rosenberg, Gary A. Schmidt, Reinhold Smith, Eric E Hainsworth, Atticus H |
| author_sort | Wallin, Anders |
| collection | PubMed |
| description | • Controversial registration of aducanumab for Alzheimer's Disease; • Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug; • Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular cognitive disorders; • The studies may give detailed phenotyping data that may lead to knowledge of targets for treatments of patients with vascular cognitive disorders. |
| format | Online Article Text |
| id | pubmed-9616233 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96162332022-11-01 What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? Wallin, Anders Alladi, Suvarna Black, Sandra E Chen, Christopher Greenberg, Steven M Gustafson, Deborah Isaacs, Jeremy D Jokinen, Hanna Kalaria, Raj Mok, Vincent Pantoni, Leonardo Pasquier, Florence Roman, Gustavo C Rosenberg, Gary A. Schmidt, Reinhold Smith, Eric E Hainsworth, Atticus H Cereb Circ Cogn Behav Editorial • Controversial registration of aducanumab for Alzheimer's Disease; • Aducanumab is the subject of post-licensing observational studies aiming to follow the effects of the drug; • Given the high prevalence of cerebrovascular pathology it is important that these studies do not ignore vascular cognitive disorders; • The studies may give detailed phenotyping data that may lead to knowledge of targets for treatments of patients with vascular cognitive disorders. Elsevier 2022-02-11 /pmc/articles/PMC9616233/ /pubmed/36324416 http://dx.doi.org/10.1016/j.cccb.2022.100044 Text en © 2022 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Wallin, Anders Alladi, Suvarna Black, Sandra E Chen, Christopher Greenberg, Steven M Gustafson, Deborah Isaacs, Jeremy D Jokinen, Hanna Kalaria, Raj Mok, Vincent Pantoni, Leonardo Pasquier, Florence Roman, Gustavo C Rosenberg, Gary A. Schmidt, Reinhold Smith, Eric E Hainsworth, Atticus H What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title | What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title_full | What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title_fullStr | What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title_full_unstemmed | What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title_short | What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? |
| title_sort | what does aducanumab treatment of alzheimer's disease mean for research on vascular cognitive disorders? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616233/ https://www.ncbi.nlm.nih.gov/pubmed/36324416 http://dx.doi.org/10.1016/j.cccb.2022.100044 |
| work_keys_str_mv | AT wallinanders whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT alladisuvarna whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT blacksandrae whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT chenchristopher whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT greenbergstevenm whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT gustafsondeborah whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT isaacsjeremyd whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT jokinenhanna whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT kalariaraj whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT mokvincent whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT pantonileonardo whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT pasquierflorence whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT romangustavoc whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT rosenberggarya whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT schmidtreinhold whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT smitherice whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders AT hainsworthatticush whatdoesaducanumabtreatmentofalzheimersdiseasemeanforresearchonvascularcognitivedisorders |